Home › Cancro del polmone non a piccole cellule › Georgia › Athens
Studi clinici su Cancro del polmone non a piccole cellule a Athens, GA
17 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Athens e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- University Cancer & Blood Center /ID# 270969, Athens
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- University Cancer & Blood Center, LLC, Athens
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
In reclutamentoFase 3
- University Cancer & Blood Center, LLC, Athens
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
In reclutamentoFase 3
- University Cancer and Blood Center, Athens
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
In reclutamentoFase 2
- University Cancer & Blood Center, LLC, Athens
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
In reclutamentoFase 3
- University Cancer & Blood Center, LLC, Athens
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- Research Site, Athens
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
In reclutamentoFase 2/3
- University Cancer & Blood Center (UCBC) - Athens, Athens
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2/3
- University Cancer and Blood Cent /ID# 261824, Athens
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- University Cancer & Blood Center, LLC, Athens
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
In reclutamentoFase 1
- University Cancer & Blood Center, Athens
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- University Cancer and Blood Center LLC, Athens
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
In reclutamentoFase 1/2
- University Cancer and Blood Center, Athens
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Athens
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- University Cancer and Blood Center LLC, Athens
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 2
- University Cancer & Blood Center, Athens
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
In reclutamentoFase 2
- University Cancer & Blood Center (UCBC) - Athens, Athens
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Athens
- Cancro ai polmoni9 studi
- Cancro (tutti i tipi)6 studi
- Cancro colorettale5 studi
- Cancro al seno5 studi
- Cancro alla prostata4 studi
- Cancro del colon3 studi
- Malattie polmonari3 studi
- Melanoma3 studi
- Schizofrenia3 studi
- Disturbi psicotici3 studi
- Cancro al seno triplo negativo3 studi
- Cancro metastatico3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.